Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers

Cancer therapies targeting the vascular endothelial growth factor (VEGF) signaling pathway can lead to renal damage by disrupting the glomerular ultrafiltration apparatus. The objective of the current study was to identify sensitive biomarkers for VEGF inhibition-induced glomerular changes in rats....

Full description

Bibliographic Details
Main Authors: Yi Yang, Kenneth Kowalkowski, Rita Ciurlionis, Wayne R. Buck, Keith B. Glaser, Daniel H. Albert, Eric A. G. Blomme
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/23/12629
_version_ 1797507763298893824
author Yi Yang
Kenneth Kowalkowski
Rita Ciurlionis
Wayne R. Buck
Keith B. Glaser
Daniel H. Albert
Eric A. G. Blomme
author_facet Yi Yang
Kenneth Kowalkowski
Rita Ciurlionis
Wayne R. Buck
Keith B. Glaser
Daniel H. Albert
Eric A. G. Blomme
author_sort Yi Yang
collection DOAJ
description Cancer therapies targeting the vascular endothelial growth factor (VEGF) signaling pathway can lead to renal damage by disrupting the glomerular ultrafiltration apparatus. The objective of the current study was to identify sensitive biomarkers for VEGF inhibition-induced glomerular changes in rats. Male Sprague-Dawley rats were administered an experimental VEGF receptor (VEGFR) inhibitor, ABT-123, for seven days to investigate the correlation of several biomarkers with microscopic and ultrastructural changes. Glomeruli obtained by laser capture microdissection were also subjected to gene expression analysis to investigate the underlying molecular events of VEGFR inhibition in glomerulus. ABT-123 induced characteristic glomerular ultrastructural changes in rats, including fusion of podocyte foot processes, the presence of subendothelial electron-dense deposits, and swelling and loss of fenestrations in glomerular endothelium. The subtle morphological changes cannot be detected with light microscopy or by changes in standard clinical chemistry and urinalysis. However, urinary albumin increased 44-fold as early as Day three. Urinary β2-microglobulin levels were also increased. Other urinary biomarkers that are typically associated with tubular injury were not significantly impacted. Such patterns in urinary biomarkers can provide valuable diagnostic insight to VEGF inhibition therapy-induced glomeruli injuries.
first_indexed 2024-03-10T04:53:04Z
format Article
id doaj.art-303ab7d571f24aa7899afe4e5febdaf2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T04:53:04Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-303ab7d571f24aa7899afe4e5febdaf22023-11-23T02:25:29ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-11-0122231262910.3390/ijms222312629Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary BiomarkersYi Yang0Kenneth Kowalkowski1Rita Ciurlionis2Wayne R. Buck3Keith B. Glaser4Daniel H. Albert5Eric A. G. Blomme6Global Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USAGlobal Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USAGlobal Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USAGlobal Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USAGlobal Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USAGlobal Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USAGlobal Pharmaceutical Research and Development, AbbVie, 1 North Waukegan Road, North Chicago, IL 60064, USACancer therapies targeting the vascular endothelial growth factor (VEGF) signaling pathway can lead to renal damage by disrupting the glomerular ultrafiltration apparatus. The objective of the current study was to identify sensitive biomarkers for VEGF inhibition-induced glomerular changes in rats. Male Sprague-Dawley rats were administered an experimental VEGF receptor (VEGFR) inhibitor, ABT-123, for seven days to investigate the correlation of several biomarkers with microscopic and ultrastructural changes. Glomeruli obtained by laser capture microdissection were also subjected to gene expression analysis to investigate the underlying molecular events of VEGFR inhibition in glomerulus. ABT-123 induced characteristic glomerular ultrastructural changes in rats, including fusion of podocyte foot processes, the presence of subendothelial electron-dense deposits, and swelling and loss of fenestrations in glomerular endothelium. The subtle morphological changes cannot be detected with light microscopy or by changes in standard clinical chemistry and urinalysis. However, urinary albumin increased 44-fold as early as Day three. Urinary β2-microglobulin levels were also increased. Other urinary biomarkers that are typically associated with tubular injury were not significantly impacted. Such patterns in urinary biomarkers can provide valuable diagnostic insight to VEGF inhibition therapy-induced glomeruli injuries.https://www.mdpi.com/1422-0067/22/23/12629vascular endothelial growth factorglomerular injuryurinary biomarkers
spellingShingle Yi Yang
Kenneth Kowalkowski
Rita Ciurlionis
Wayne R. Buck
Keith B. Glaser
Daniel H. Albert
Eric A. G. Blomme
Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
International Journal of Molecular Sciences
vascular endothelial growth factor
glomerular injury
urinary biomarkers
title Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
title_full Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
title_fullStr Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
title_full_unstemmed Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
title_short Identification of VEGF Signaling Inhibition-Induced Glomerular Injury in Rats through Site-Specific Urinary Biomarkers
title_sort identification of vegf signaling inhibition induced glomerular injury in rats through site specific urinary biomarkers
topic vascular endothelial growth factor
glomerular injury
urinary biomarkers
url https://www.mdpi.com/1422-0067/22/23/12629
work_keys_str_mv AT yiyang identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers
AT kennethkowalkowski identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers
AT ritaciurlionis identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers
AT waynerbuck identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers
AT keithbglaser identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers
AT danielhalbert identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers
AT ericagblomme identificationofvegfsignalinginhibitioninducedglomerularinjuryinratsthroughsitespecificurinarybiomarkers